Fermenta Biotech opened higher at ₹527.00, compared with its previous close of ₹518.40. During today's session, the stock has traded between ₹506.10 and ₹527.00, with an average traded price of ₹514.74. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 1 year ago in Fermenta Biotech is now worth
₹ 16,363.00
giving a profit of
₹ 6,363.00 (63.63%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+2.60 (+0.50%)
Day High
₹527.00
Day Low
₹506.10
Day Open
₹527.00
Prev Close
₹518.40
Volume
55,762
Value Traded
₹2.87 Cr
1W Return
-6.54%
1M Return
9.77%
3M Return
26.52%
6M Return
63.63%
1Y Return
63.63%
Market Cap (₹ Cr.)
1,533
PE Ratio
26.30
PB Ratio
3.76
Dividend Yield
0.72%
ROE
17.54%
ROCE
24.46%
Book Value (₹)
138.15
Face Value (₹)
5.00
EPS (TTM)
3.40
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-6.54%
6 Week
-
1 Month
9.77%
3 Month
26.52%
9 Month
63.63%
Fermenta Biotech to host investor meeting in Dahej on Oct 15
Fermenta Biotech will hold a group investor meeting on October 15, 2026. The event will be conducted physically in Dahej, Gujarat. No unpublished price sensitive information will be discussed during the meeting.
YesterdayFermenta Biotech shifts one-to-one investor meeting to Oct 7
Fermenta Biotech rescheduled its one-to-one investor meeting to October 7, 2026. The event will be held physically in Mumbai, replacing the earlier October 5 date. No unpublished price-sensitive information (UPSI) will be discussed during the session.
12 days agoFermenta Biotech promoter Preeti Thakkar sells 3.96% stake
Preeti Thakkar sold 11,65,938 shares in Fermenta Biotech. Sale represented 3.96% of total equity share capital. Promoter holding reduced from 7.61% to 3.65%. Transaction conducted via open market on September 28, 2026.
13 days agoFermenta Biotech to host physical investor meeting in Mumbai on Sep 22
Fermenta Biotech will hold a physical one-to-one investor meeting in Mumbai on September 22, 2026. The disclosure was filed on September 17, 2026, under Regulation 30 of SEBI LODR Regulations. No unpublished price-sensitive information (UPSI) will be shared during the interaction. Company officials will discuss updates using publicly available presentations and press releases.
26 days agoFermenta Biotech signs exclusive licence with VIT for Vitamin B12 tech
Exclusive licence covers natural in-situ Vitamin B12 fortification for fermented foods. Technology developed by VIT Vellore under Indian Patent Application No. 202441015300. Lab studies show approximately 80% retention of Vitamin B12 levels after cooking. Deal aims to address deficiencies in vegetarian populations via curd, idli, and breads. Next steps include regulatory evaluation and commercial solution development.
1mo agoFermenta Biotech to host physical investor meeting in Mumbai on Sep 3
Fermenta Biotech to host physical one-to-one investor meeting. Interaction scheduled for September 3, 2026, in Mumbai. No unpublished price-sensitive information to be discussed. Compliance with SEBI LODR Regulation 30 confirmed.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 1 year ago in Fermenta Biotech is now worth
₹ 16,363.00
giving a profit of
₹ 6,363.00 (63.63%)
Note: Past profits do not guarantee future returns.
